Abstract
The obesity hypoventilation syndrome (OHS) characterized by persistent hypercapnia with obesity has many causes. Probably the most common cause is the obstructive sleep apnea syndrome and related conditions, but some cases may occur along with depressed chemosensitivity and few apneas during sleep. The mechanisms that produce waking hypercapnia are still uncertain. Treatment of OHS consists of weight management and sometimes requires treatment with continuous applied pressure or non invasive positive pressure ventilation.
Current Respiratory Medicine Reviews
Title: The Obesity Hypoventilation Syndrome
Volume: 4 Issue: 2
Author(s): Neil S. Cherniack
Affiliation:
Abstract: The obesity hypoventilation syndrome (OHS) characterized by persistent hypercapnia with obesity has many causes. Probably the most common cause is the obstructive sleep apnea syndrome and related conditions, but some cases may occur along with depressed chemosensitivity and few apneas during sleep. The mechanisms that produce waking hypercapnia are still uncertain. Treatment of OHS consists of weight management and sometimes requires treatment with continuous applied pressure or non invasive positive pressure ventilation.
Export Options
About this article
Cite this article as:
Cherniack S. Neil, The Obesity Hypoventilation Syndrome, Current Respiratory Medicine Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339808784222740
DOI https://dx.doi.org/10.2174/157339808784222740 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Lipid Lowering Agents, Inflammation and Atherosclerosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Processed Foods, Dysbiosis, Systemic Inflammation, and Poor Health
Current Nutrition & Food Science Design of NAALADase Inhibitors A Novel Neuroprotective Strategy
Current Medicinal Chemistry Novel Therapeutic Strategy in the Management of COPD: A Systems Medicine Approach
Current Medicinal Chemistry Molecular Targets of Diabetic Cardiovascular Complications
Current Drug Targets Possible Consequences of Blocking Transient Receptor Potential Vanilloid 1
Current Pharmaceutical Biotechnology Molecular Targeted Agents Combined with Chemo-Radiation in the Treatment of Locally Advanced Cervix Cancer
Reviews on Recent Clinical Trials Combining Growth Factor and Stem Cell Therapy for Stroke Rehabilitation, A Review
Current Drug Targets Editorial [Hot Topic Cardiovascular and Metabolic Diseases: from Mechanisms to Novel Therapeutical Implications Guest Editors: Attila Borbély and Pawel Petkow Dimitrow]
Current Pharmaceutical Biotechnology Effect of Soy Isoflavone Supplementation on Endothelial Dysfunction and Oxidative Stress in Equol-Producing Postmenopausal Women
Endocrine, Metabolic & Immune Disorders - Drug Targets Nutrition in Allogeneic Stem Cell Transplantion - Clinical Guidelines and Immunobiological Aspects
Current Pharmaceutical Biotechnology Crucial Role of Interferon-γ and Stimulated Macrophages in Cardiovascular Disease
Current Vascular Pharmacology Anti-Oxidant Gene Therapy by NFkB Decoy Oligodeoxynucleotide
Current Pharmaceutical Biotechnology Adiponectin and its Receptors as Potential Therapeutical Targets
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Mechanisms of Focal Adhesion Kinase Regulation
Current Cancer Drug Targets Conantokins: Peptide Antagonists of NMDA Receptors
Current Medicinal Chemistry Molecular Mechanisms of Restenosis After Percutaneous Peripheral Angioplasty and Approach to Endovascular Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Inflammation, Atrial Fibrillation and Cardiac Surgery: Current Medical and Invasive Approaches for the Treatment of Atrial Fibrillation
Current Pharmaceutical Design Neurotrophic Factors in Combination: A Possible new Therapeutic Strategy to Influence Pathophysiology of Spinal Cord Injury and Repair Mechanisms
Current Pharmaceutical Design Neurological Involvement in Rheumatoid Arthritis
Current Immunology Reviews (Discontinued)